Lupus (SLE): vizsgálatok itt: Egyesült Államok
79 of 100 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleAutologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
- Where
- Philadelphia
- Életkor
- 8 év to 25 év
- People
- 20
- Run by
- Stephan Grupp MD PhD
See details and how to joinNCT05029336 - 3. fázisCsak meghívásosA Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
- Where
- Atlanta, Avondale, Beckley, Bellaire, Beverly Hills, Birmingham, Brandon, Canton, Charlotte, Chicago, Colleyville, Denver, Detroit, Gainesville, Glendale, Hagerstown, Hershey, Hopkinsville, Idaho Falls, Jackson, Lake Charles, La Palma, Las Vegas, Manhasset, Miami, New Orleans, New York, Ormond Beach, Phoenix, Plantation, San Leandro, Tampa, Tucson
- Életkor
- 16 év and over
- People
- 760 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT04976322 · EU 2023-506368-14-00 - No phaseTaking peopleTransforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- Where
- Birmingham, Cincinnati, Grand Rapids, New Orleans, Seattle, The Bronx
- Életkor
- 12 év to 22 év
- People
- 175 worldwide
- Run by
- Michigan State University
See details and how to joinNCT06232304 - 3. fázisTaking peopleA Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Where
- Anniston, Austin, Baytown, Birmingham, Brandon, Colleyville, Edinburg, Fontana, Houston, Kansas City, La Jolla, Lake Charles, La Palma, Memphis, Menifee, Miami, New Albany, Oklahoma City, Phoenix, San Leandro, Silver Spring, Spokane, St. Petersburg, Sugar Land, Temecula, Tucson, West Long Branch, Willowbrook
- Életkor
- 18 év to 70 év
- People
- 245 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07430306 - 1. fázisTaking peopleTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Where
- Atlanta, Baltimore, Bethesda, Birmingham, Boston, Chicago, City of Saint Peters, Columbus, Creve Coeur, Dallas, Detroit, Fairway, Fort Worth, Hays, Houston, Kansas City, Lawrence, Lee's Summit, Lexington, Mineola, New Brunswick, New Haven, New York, North Kansas City, Olathe, Overland Park, Palo Alto, Philadelphia, Pittsburg, Pittsburgh, Richardson, Richmond, Sacramento, Salina, Salt Lake City, St Louis, Topeka, Washington D.C., Westwood
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03816345 - 2. fázisTaking peopleA Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Where
- Amarillo, Aventura, Beverly Hills, Brandon, Charlotte, Clearwater, Colleyville, Denver, Duncansville, Euless, Fayetteville, Frisco, Grand Blanc, Great Falls, Houston, Jackson, Katy, Lansing, La Palma, Memphis, Mesquite, Middleburg Heights, Oklahoma City, Plantation, San Diego, Tampa, Torrance, Upland, West Hills
- Életkor
- 18 év to 74 év
- People
- 405 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07409181 · EU 2025-523488-39-00 - 3. fázisTaking peopleRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Where
- Ann Arbor, Baltimore, Boca Raton, Boston, Charleston, Charlotte, Chicago, Cleveland, Columbus, Dallas, Fort Lauderdale, Indianapolis, Irvine, Los Angeles, New York, Omaha, Phoenix, Portland, Roanoke, Rochester, San Francisco
- Életkor
- 5 év to 80 év
- People
- 1072 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07691970 - 3. fázisTaking peopleA Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous Manifestations Of Lupus With Or Without Systemic Disease [Elowen-LTE]
- Where
- Troy
- Életkor
- 18 év to 76 év
- People
- 404
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07840287 · EU 2026-525294-39-00 - 3. fázisTaking peoplePhase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Where
- Anniston, Aurora, Baltimore, Bellaire, Burbank, Clearwater, Cooper City, Detroit, Grand Blanc, Homestead, Jackson, Lake Charles, La Palma, Lawrenceville, League City, Memphis, Middleburg Heights, New Orleans, Pittsburgh, Plantation, Red Oak, Skokie, Tampa, Westlake Village, Willowbrook
- Életkor
- 12 év to 100 év
- People
- 550 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06133972 · EU 2023-505929-14-00 - 3. fázisTaking peoplePhase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
- Where
- Orchard Park
- Életkor
- 18 év to 100 év
- People
- 348 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06711887 · EU 2024-515280-60-00 - 4. fázisTaking peopleDapagliflozin in Active Lupus Nephritis
- Where
- Boston
- Életkor
- 18 év to 70 év
- People
- 33
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT07323524 - 3. fázisTaking peopleA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Where
- Allen, Atlanta, Cooper City, Corpus Christi, Los Angeles, Miami, Tamarac, Tampa, Thousand Oaks, Troy
- Életkor
- 18 év to 75 év
- People
- 202 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07332481 · EU 2025-523871-44-00 - 3. fázisTaking peopleA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Where
- Auburn Hills, Charlotte, DeBary, Fort Lauderdale, Frisco, Hollywood, Houston, Humble, Indianapolis, Lake Charles, Miami, Pembroke Pines, Smithfield, Tampa, Upland
- Életkor
- 18 év to 75 év
- People
- 202 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07355218 · EU 2025-524855-30-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Where
- Atlanta, Aurora, Cincinnati, El Paso, Hackensack, Indianapolis, Loma Linda, Philadelphia, Queens, San Francisco, Shreveport
- Életkor
- 5 év to 17 év
- People
- 40 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05039619 · EU 2023-505825-15-00 - 1/2. fázisTaking peoplePhase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- Where
- Houston
- Életkor
- 18 év and over
- People
- 47
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06434363 - 3. fázisTaking peopleA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Where
- Amarillo, Atlanta, Aventura, Beverly Hills, Charlotte, Clearwater, Denver, Fayetteville, Frisco, Hemet, Hialeah, Jackson, Katy, Lake Charles, La Palma, Marietta, Mesquite, Miami, Miami Gardens, Miami Lakes, Middleburg Heights, Mission Viejo, Newark, Oklahoma City, Philadelphia, Plano, Plantation, Red Oak, Roanoke, San Leandro, Sterling Heights, Sugar Land, Tampa, Torrance, Tustin, Upland, Voorhees Township, Willowbrook
- Életkor
- 18 év to 75 év
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07438496 · EU 2025-523552-31-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Where
- Aurora, Avondale, Baton Rouge, Bellaire, Beverly Hills, Brandon, Brooklyn, Chandler, Charlotte, Chicago, Clearwater, Coral Gables, Detroit, El Paso, Fort Worth, Frisco, Gainesville, Gilbert, Glendale, Grapevine, Hollywood, Houston, Iowa City, Jackson, Kansas City, La Jolla, Lake Charles, La Palma, Los Alamitos, Los Angeles, Louisville, Manhasset, Mansfield, Margate, Marietta, Menifee, Mesquite, Miami, Murfreesboro, New Albany, New Orleans, New York, Oklahoma City, Orange, Phoenix, Pittsburgh, Plantation, Rockville, San Leandro, Scottsdale, Searcy, Spokane Valley, Syracuse, Tampa, Willowbrook, Winter Park
- Életkor
- 16 év and over
- People
- 450 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06617325 · EU 2023-508191-11-00 - 1. fázisTaking peopleA Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Where
- Aurora, Baltimore, Charleston, Charlotte, Chicago, Durham, East Brunswick, Greenville, Iowa City, Jacksonville, Kansas City, Loma Linda, Louisville, New York, Phoenix, Salt Lake City, Valhalla
- Életkor
- 18 év to 74 év
- People
- 66 worldwide
- Run by
- Allogene Therapeutics
See details and how to joinNCT07085104 - 2. fázisTaking peopleObe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Where
- Houston, New York, San Antonio, Syracuse
- Életkor
- 12 év to 65 év
- People
- 35 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT07053800 · EU 2024-519941-32-00 - 4. fázisTaking peopleSafety of the Herpes Zoster Subunit Vaccine in Lupus
- Where
- New York, Oklahoma City
- Életkor
- 18 év to 90 év
- People
- 224
- Run by
- NYU Langone Health
See details and how to joinNCT05559671 - 1. fázisTaking peopleStudy Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Where
- Allen, Birmingham, Fullerton, Mesquite, Plantation, St Louis
- Életkor
- 18 év to 65 év
- People
- 48 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07201558 · EU 2025-522273-10-00 - 1. fázisTaking peopleDose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- Where
- Gainesville, Houston, Rochester, San Francisco
- Életkor
- 18 év to 60 év
- People
- 90 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06975787 · EU 2024-518288-37-00 - 1. fázisTaking peopleA Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Where
- Avondale, Boston, Iowa City, Memphis, New York, Orlando, Plano, Rochester, Salt Lake City, Tucson, Webster
- Életkor
- 18 év to 70 év
- People
- 24 worldwide
- Run by
- Cullinan Therapeutics Inc.
See details and how to joinNCT06613360 · EU 2024-518780-36-00 - 1. fázisTaking peopleA Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- Where
- Boston, Chapel Hill, Chicago, Iowa City, La Jolla, New Orleans, Portland, Redwood City, St Louis
- Életkor
- 18 év to 70 év
- People
- 80 worldwide
- Run by
- CRISPR Therapeutics
See details and how to joinNCT06925542 - 1. fázisTaking peopleA Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Where
- Anniston, Clearwater, Greenacres City, Houston, Jackson, Kissimmee, Miami, Orland Park, Plantation, Red Oak, Tampa, Tustin
- Életkor
- 18 év to 75 év
- People
- 30 worldwide
- Run by
- AbbVie
See details and how to joinNCT07607964